Human Monocytes Engage an Alternative Inflammasome Pathway

Area of Science:

• Immunology
• Cell Biology

Background:

• Interleukin-1β (IL-1β) is a key cytokine regulated by inflammasome activation.
• Lipopolysaccharide (LPS) typically activates classical inflammasome pathways, but human monocytes show unique IL-1β secretion independent of these stimuli.

Purpose of the Study:

• To investigate the mechanism of LPS-induced IL-1β secretion in human monocytes.
• To characterize the novel
• alternative inflammasome
• pathway and its upstream signaling.

Main Methods:

• Utilized a monocyte transdifferentiation system for genetic dissection of signaling pathways.
• Analyzed inflammasome characteristics including pyroptosome formation, pyroptosis, and K(+) efflux.
• Investigated Toll-like receptor 4 (TLR4) signaling components.

Main Results:

• Human monocytes, unlike murine models, exhibit a species-specific LPS response involving an alternative inflammasome.
• This alternative pathway relies on NLRP3-ASC-caspase-1 but lacks classical inflammasome features like pyroptosis and K(+) efflux.
• TLR4-TRIF-RIPK1-FADD-CASP8 signaling propagates alternative inflammasome activation upstream of NLRP3.

Conclusions:

• A novel TLR4-driven signaling cascade mediates alternative inflammasome activation in human monocytes.
• This pathway is distinct from classical NLRP3 inflammasome activation.
• The alternative inflammasome plays a crucial role in human TLR4-mediated immune responses and immunopathology.